Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 2, 2024 (Week 09)

column labels (in same order that data fields appears in each record below):
Reporting Area
Carbapenemase-Producing Organisms (CPO), Total §; Current week
Carbapenemase-Producing Organisms (CPO), Total §; Previous 52 weeks Max +
Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2024 +
Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2023 +

tab delimited data:
U.S. Residents, excluding U.S. Territories	16	NC	489	877	
New England	-	NC	5	4	
Connecticut	-	NC	-	-	
Maine	-	NC	-	-	
Massachusetts	-	NC	-	-	
New Hampshire	-	NC	5	4	
Rhode Island	-	NC	-	-	
Vermont	-	NC	-	-	
Middle Atlantic	2	NC	25	151	
New Jersey	-	NC	-	-	
New York (excluding New York City)	-	NC	-	-	
New York City	-	NC	-	37	
Pennsylvania	2	NC	25	114	
East North Central	14	NC	318	226	
Illinois	-	NC	-	1	
Indiana	-	NC	35	62	
Michigan	-	NC	-	39	
Ohio	14	NC	283	116	
Wisconsin	-	NC	-	8	
West North Central	-	NC	12	25	
Iowa	-	NC	-	9	
Kansas	-	NC	12	16	
Minnesota	-	NC	-	-	
Missouri	-	NC	-	-	
Nebraska	-	NC	-	-	
North Dakota	-	NC	-	-	
South Dakota	-	NC	-	-	
South Atlantic	-	NC	14	117	
Delaware	-	NC	-	1	
District of Columbia	-	NC	-	-	
Florida	N	NC	N	N	
Georgia	-	NC	-	53	
Maryland	-	NC	-	-	
North Carolina	-	NC	-	21	
South Carolina	-	NC	-	-	
Virginia	-	NC	-	35	
West Virginia	-	NC	14	7	
East South Central	-	NC	-	21	
Alabama	N	NC	N	N	
Kentucky	-	NC	-	-	
Mississippi	-	NC	-	21	
Tennessee	-	NC	-	-	
West South Central	-	NC	-	5	
Arkansas	-	NC	-	-	
Louisiana	-	NC	-	5	
Oklahoma	-	NC	-	-	
Texas	-	NC	-	-	
Mountain	-	NC	86	121	
Arizona	-	NC	86	115	
Colorado	-	NC	-	-	
Idaho	-	NC	-	-	
Montana	-	NC	-	-	
Nevada	-	NC	-	2	
New Mexico	-	NC	-	-	
Utah	-	NC	-	3	
Wyoming	-	NC	-	1	
Pacific	-	NC	29	207	
Alaska	-	NC	-	-	
California	-	NC	-	197	
Hawaii	-	NC	-	2	
Oregon	-	NC	29	6	
Washington	-	NC	-	2	
U.S. Territories	-	NC	-	20	
American Samoa	-	NC	-	-	
Commonwealth of Northern Mariana Islands	-	NC	-	-	
Guam	-	NC	-	-	
Puerto Rico	-	NC	-	20	
U.S. Virgin Islands	-	NC	-	-	
Non-U.S. Residents	-	NC	-	-	
Total	16	NC	489	897	

U: Unavailable - The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases - The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable - The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. 
NN: Not nationally notifiable - This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated - There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
* Case counts for reporting years 2023 and 2024 are provisional and subject to change.
For further information on interpretation of these data, see  
https://www.cdc.gov/nndss/data-statistics/readers-guides/
§ Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.